Cite
HARVARD Citation
Nakamura, Z. et al. (2023). A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects. Cancer medicine. pp. 8172-8183. [Online].